Lantern Pharma Inc

General ticker "LTRN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $37.1M

Lantern Pharma Inc does not follow the US Stock Market performance with the rate: -12.2%.

Estimated limits based on current volatility of 4.8%: low 2.95$, high 3.25$

Factors to consider:

  • Earnings for 18 months up through Q2 (+1 year) are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2022-12-31 to 2024-12-30

  • 2022-12-31 to 2023-12-31 estimated range: [3.21$, 7.51$]
  • 2023-12-31 to 2024-12-30 estimated range: [3.05$, 7.13$]

Financial Metrics affecting the LTRN estimates:

  • Negative: Non-GAAP EPS, $ of -1.31 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -18.21 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -21.66 <= 3.85
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term LTRN quotes

Long-term LTRN plot with estimates

Financial data

YTD 2020-12-31 2021-12-31 2022-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $5.91MM $12.59MM $14.43MM
Operating Income $-5.91MM $-12.59MM $-14.43MM
Non-Operating Income $0.00MM $0.07MM $0.20MM
Interest Expense $0.00MM $0.00MM $0.20MM
R&D Expense $2.24MM $7.57MM $8.60MM
Income(Loss) $-5.91MM $-12.52MM $-14.23MM
Profit(Loss) $-5.91MM $-12.52MM $-14.23MM
Stockholders Equity $19.70MM $71.57MM $56.04MM
Inventory $0.00MM $0.18MM $0.59MM
Assets $20.36MM $73.95MM $58.84MM
Operating Cash Flow $-5.65MM $-10.59MM $-12.77MM
Capital expenditure $0.02MM $0.02MM $0.03MM
Investing Cash Flow $-0.02MM $-19.53MM $0.18MM
Financing Cash Flow $23.66MM $63.42MM $-2.18MM
Earnings Per Share* $-0.95 $-1.13 $-1.30

* EPS are Split Adjusted, recent splits may be reflected with a delay.